Howard Koh
Primary Faculty

Howard Koh

Harvey V. Fineberg Professor of the Practice of Public Health Leadership

Health Policy and Management

hkoh@hsph.harvard.edu

Other Positions

Affiliate of the Harvard Kennedy School

Faculty Members

Harvard Kennedy School


Overview

Dr. Howard K. Koh is the Harvey V. Fineberg Professor of the Practice of Public Health Leadership at the Harvard T. H. Chan School of Public Health as well as a member of the Faculty Executive Committee of the Harvard Advanced Leadership Initiative. In these roles, he advances interdisciplinary leadership education and training at the Harvard T.H. Chan School of Public Health as well as across Harvard University. He also serves as the inaugural Chair of the Harvard T. H. Chan School of Public Health Initiative on Health and Homelessness and Co-Director of the Initiative on Health, Spirituality and Religion at Harvard University. Previously at Harvard School of Public Health (2003-2009), he was Associate Dean for Public Health Practice and Director of the School’s Center for Public Health Preparedness.

From 2009-2014, Dr. Koh was the 14th Assistant Secretary for Health for the U.S. Department of Health and Human Services (HHS), after being nominated by President Barack Obama and being confirmed by the U.S. Senate. During that time, he oversaw 12 core public health offices, including the Office of the Surgeon General and the U.S. Public Health Service Commissioned Corps, 10 Regional Health Offices across the nation, and 10 Presidential and Secretarial advisory committees. He served as senior public health advisor to the HHS Secretary and in that capacity oversaw Healthy People 2020 (the nation’s public health agenda), promoted the disease prevention and public health dimensions of the Affordable Care Act, advanced outreach to enroll underserved and minority populations into health insurance coverage, helped to coordinate federal response during the 2009 H1N1 pandemic and was the primary architect of landmark HHS strategic plans for tobacco control, chronic hepatitis and health disparities (including Asian American Native Hawaiian and Pacific Islander health). He led interdisciplinary implementation of the National HIV/AIDS Strategy as well as initiatives in nutrition and physical activity (including HHS activities for Let’s Move!), cancer control, adult immunization, environmental health and climate change, women’s health, adolescent health, behavioral health and substance use disorders, health literacy, multiple chronic conditions, organ donation and epilepsy. His national service also includes a term on the National Cancer Advisory Board (2000-2002) after being appointed by President Bill Clinton.

In his academic career, Dr. Koh has been Principal Investigator for over $28 million in research grant activities and published more than 325 articles in the medical and public health literature. His publications and writing address broad areas, such as disease prevention and health promotion, health reform, health equity (including Asian American, Native Hawaiian and Pacific Islander health), health and spirituality, public health emergency preparedness and the Covid-19 pandemic, health literacy and public health leadership. He has also published on specific topics such as tobacco control and cancer control, melanoma and skin oncology, the opioid crisis, health issues of the homeless, chronic hepatitis, climate change, organ donation and epilepsy.

From 1997-2003, Dr. Koh was Commissioner of Public Health for the Commonwealth of Massachusetts after being appointed by Governor William Weld. As Commissioner, he led the Massachusetts Department of Public Health, which included a wide range of health services, four hospitals, and more than 3,000 health professionals. He emphasized the power of prevention and strengthened the state’s commitment to eliminating health disparities, while advancing progress in areas such as tobacco control, bioterrorism response after 9/11 and anthrax, newborn screening, organ donation, suicide prevention and international public health partnerships.

Dr. Koh graduated from Yale College, where he was President of the Yale Glee Club, and the Yale University School of Medicine. He completed postgraduate training at Boston City Hospital and Massachusetts General Hospital, serving as chief resident in both hospitals. He has earned board certification in four medical fields: internal medicine, hematology, medical oncology, and dermatology, as well as a Master of Public Health degree from Boston University. At Boston University Schools of Medicine and Public Health, he was Professor of Dermatology, Medicine and Public Health as well as Director of Cancer Prevention and Control.

Dr. Koh has earned over 70 awards and honors for interdisciplinary accomplishments in medicine and public health, including six honorary doctorate degrees. He has received the Dr. Martin Luther King Jr. Legacy Award for National Service and the Distinguished Service Award from the American Cancer Society. He was awarded the 2014 Sedgwick Memorial Medal from the American Public Health Association (APHA) (its highest honor) and at the same time was named one of the four inaugural inductees into the APHA’s Asian Pacific Islander Caucus. He is an elected member of the National Academy of Medicine (formerly the Institute of Medicine). A past Chair of the Massachusetts Coalition for a Healthy Future (the group that pushed for the Commonwealth’s groundbreaking tobacco control initiative), Dr. Koh was recognized by the New England Division of the American Cancer Society as “one of the most influential persons in the fight against tobacco during the last 25 years”. He was named to the K100 (the 100 leading Korean Americans in the first century of Korean immigration to the United States) and has received the Boston University Distinguished Alumnus Award. He has been recognized by Modern Healthcare as one of the country’s Top 100 Most Influential People in Healthcare as well as one of the Top 25 Minority Executives in Healthcare. A popular national speaker, he has delivered 18 commencement speeches at universities, medical schools and public health schools. In 2019, HHS established the annual Dr. Howard K. Koh Award for Excellence in Leadership, sponsored by the Federal Asian Pacific American Council.

Other recognition includes the Champion Award from the Campaign for Tobacco Free Kids, the Hero of Epilepsy Award from the Epilepsy Foundation, the Distinguished National Leadership Award from the National Colorectal Cancer Roundtable, the Baruch S. Blumberg Prize from the Hepatitis B Foundation, the National Leadership Award from the Community Anti-Drug Coalitions of America (CADCA) and the Dr. Jim O’Connell Award from the Boston Healthcare for the Homeless Program. In 2021, he was named the inaugural Bayer Fellow in Health and Biotech at the American Academy in Berlin and in 2022 he received the Berlin Prize from the American Academy in Berlin. He enjoys the distinction of throwing out the ceremonial first pitch on two different occasions: at Nationals Park (2011) in Washington DC on behalf of HHS and at Fenway Park (2003) where he was designated a “Medical All Star” by the Boston Red Sox in recognition of his national contributions to the field of early detection and prevention of melanoma.

He serves on the Board of Directors of the Journal of the American Medical Association (JAMA) and the Truth Initiative. Dr. Koh and his wife Dr. Claudia Arrigg are the proud parents of three adult children and the proud grandparents of five grandchildren.


News

Homelessness ‘undermining the very fabric of our society’

A sharp uptick in homelessness in the U.S.—driven by high rents, shrinking public assistance, a lack of affordable housing, and fallout from the COVID pandemic—represents “a hard and complicated public health issue,” according to Harvard Chan School’s Howard…

Addressing the U.S. homelessness crisis

At a recent virtual event co-sponsored by Harvard Chan School’s Initiative on Health and Homelessness, experts shared the latest statistics on homelessness and discussed approaches to tackling the complex issue.